The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
    1. About this group
    2. Reviews
      1. Abdominal drainage versus no drainage post-gastrectomy for gastric cancerReview
      2. Acupuncture for functional dyspepsiaReview
      3. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughReview
      4. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitisReview
      5. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescentsReview
      6. Antioxidants for pain in chronic pancreatitisReview
      7. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleedingReview
      8. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disordersReview
      9. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview
      10. Chemotherapy for advanced gastric cancerReview
      11. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionReview
      12. Chinese herbal medicine for oesophageal cancerReview
      13. Chinese herbal medicines for acute pancreatitisReview
      14. Chinese herbal medicines for induction of remission in advanced or late gastric cancerReview
      15. Cisapride treatment for gastro-oesophageal reflux in childrenReview
      16. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagusReviewWithdrawn
      17. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingReview
      18. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerReviewDiagnostic
      19. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerReviewDiagnostic
      20. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitisReview
      21. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitisReview
      22. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitisReview
      23. Endoscopic mucosal resection for early gastric cancerReview
      24. Endoscopic or surgical intervention for painful obstructive chronic pancreatitisReview
      25. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaReview
      26. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitisReviewWithdrawn
      27. Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgeryReview
      28. Enteral nutrition formulations for acute pancreatitisReview
      29. Enteral versus parenteral nutrition for acute pancreatitisReview
      30. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcersReview
      31. Eradication of Helicobacter pylori for non-ulcer dyspepsiaReviewWithdrawn
      32. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive peopleReview
      33. Extent of lymph node dissection for adenocarcinoma of the stomachReview
      34. Fasting for haemostasis in children with gastrointestinal bleedingReviewNew
      35. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgeryReview
      36. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReview
      37. Helicobacter pylori eradication for the prevention of gastric neoplasiaReview
      38. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerReview
      39. Initial management strategies for dyspepsiaReview
      40. Interventions for dysphagia in oesophageal cancerReview
      41. Interventions for necrotising pancreatitisReviewNew
      42. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adultsReview
      43. Laparoscopic repair for perforated peptic ulcer diseaseReview
      44. Laparoscopic versus open distal pancreatectomy for pancreatic cancerReviewNew
      45. Laparoscopic versus open gastrectomy for gastric cancerReview
      46. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancerReview
      47. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesionsReview
      48. Management strategies for pancreatic pseudocystsReviewNew
      49. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseReviewWithdrawn
      50. Medical treatments in the short term management of reflux oesophagitisReviewWithdrawn
      51. Medical versus surgical treatment for refractory or recurrent peptic ulcerReview
      52. Metoclopramide for post-pyloric placement of naso-enteral feeding tubesReview
      53. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two yearsReview
      54. Neoadjuvant chemotherapy versus none for resectable gastric cancerReviewWithdrawn
      55. Nitrates for achalasiaReview
      56. Non-surgical interventions for eosinophilic esophagitisReview
      57. Non-surgical versus surgical treatment for oesophageal cancerReview
      58. Omentoplasty for oesophagogastrostomy after oesophagectomyReview
      59. Opioids for acute pancreatitis painReview
      60. Optimum duration of regimens for Helicobacter pylori eradicationReview
      61. Palliative biliary stents for obstructing pancreatic carcinomaReview
      62. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReviewNew
      63. Pancreatic enzymes for chronic pancreatitisReview
      64. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbancesReview
      65. Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbancesReview
      66. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infectionReview
      67. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusReview
      68. Pharmacological interventions for non-ulcer dyspepsiaReviewWithdrawn
      69. Pharmacological treatment of children with gastro-oesophageal refluxReview
      70. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerReview
      71. Pregabalin for decreasing pancreatic pain in chronic pancreatitisReview
      72. Preoperative chemotherapy for resectable thoracic esophageal cancerReview
      73. Preoperative radiotherapy for esophageal carcinomaReview
      74. Prevention of NSAID-induced gastroduodenal ulcersReview
      75. Prophylactic abdominal drainage for pancreatic surgeryReview
      76. Prophylactic gastrojejunostomy for unresectable periampullary carcinomaReview
      77. Proton pump inhibitor treatment for acute peptic ulcer bleedingReview
      78. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingReview
      79. Psychological interventions for non-ulcer dyspepsiaReviewWithdrawn
      80. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaReview
      81. Red cell transfusion for the management of upper gastrointestinal haemorrhageReview
      82. Resection versus other treatments for locally advanced pancreatic cancerReview
      83. Screening for oesophageal cancerReview
      84. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseReview
      85. Somatostatin analogues for pancreatic surgeryReview
      86. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomyReview
      87. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomyReview
      88. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusReview
      89. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerReview
      90. Tranexamic acid for upper gastrointestinal bleedingReview
      91. Treatment for Barrett's oesophagusReview
    3. Protocols
      1. Adjuvant therapy for resected pancreatic cancerProtocol
      2. Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux DiseaseProtocol
      3. Antecolic versus retrocolic reconstruction for prevention of delayed gastric emptying after partial pancreaticoduodenectomyProtocol
      4. Antidepressants and anxiolytics for functional dyspepsiaProtocol
      5. Antioxidants for acute pancreatitisProtocol
      6. Antiproteases for acute pancreatitisProtocol
      7. Biodegradable anastomotic ring for gastrointestinal anastomosisProtocol
      8. Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in childrenProtocolDiagnostic
      9. Carbon dioxide detection for testing nasogastric tube placement in adultsProtocolDiagnostic
      10. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerProtocol
      11. Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerProtocol
      12. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsProtocol
      13. Chinese herbal medicine for advanced pancreatic cancerProtocol
      14. Conservative interventions for the management of impacted food bolus in the oesophagusProtocol
      15. Deprescribing versus continuation of chronic proton pump inhibitor use in adultsProtocol
      16. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerProtocolDiagnostic
      17. Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocol
      18. Endoscopic drainage with or without endo-ultrasonography for pancreatic pseudocystProtocol
      19. Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocolWithdrawn
      20. Eradication of Helicobacter pylori for iron deficiencyProtocol
      21. Erlotinib for advanced pancreatic cancerProtocol
      22. Erythromycin and related macrolides for gastroparesisProtocolNew
      23. Extended lymph node resection versus standard resection for pancreatic and peri-ampullary adenocarcinomaProtocol
      24. Helicobacter pylori eradication for premalignant lesions of the gastric mucosaProtocol
      25. High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitisProtocol
      26. Imaging modalities for characterising focal pancreatic lesionsProtocolDiagnostic
      27. Imatinib mesylate for gastrointestinal stromal tumours (GISTs)ProtocolWithdrawn
      28. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsProtocol
      29. Interventions for the management of esophageal candidiasis in immunocompromised patientsProtocol
      30. Intraperitoneal chemotherapy for gastric carcinomaProtocol
      31. Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasiaProtocol
      32. Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adultsProtocol
      33. Lexipafant for acute pancreatitisProtocol
      34. Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatusProtocol
      35. Minimal access drainage procedures for patients with necrotising pancreatitisProtocol
      36. Molecular-targeted therapy for advanced gastric cancerProtocol
      37. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitisProtocol
      38. Non-invasive diagnostic tests for Helicobacter pylori infectionProtocolDiagnostic
      39. Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachProtocol
      40. Optimum antibiotic doses for Helicobacter pylori eradicationProtocol
      41. Optimum second-line regimens for Helicobacter pylori eradicationProtocol
      42. Pancreatic amylase in drain fluid for the diagnosis of pancreatic leak in post pancreatic resectionProtocolDiagnostic
      43. Perioperative corticosteroids for reducing postoperative complications following esophagectomyProtocol
      44. Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancerProtocol
      45. Pharmacological interventions for acute pancreatitis: a network meta-analysisProtocol
      46. Postoperative chemotherapy or radiotherapy for esophageal cancerProtocol
      47. Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancerProtocol
      48. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionProtocol
      49. Prokinetics for functional dyspepsiaProtocol
      50. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradicationProtocol
      51. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseProtocol
      52. Proton pump inhibitors for functional dyspepsiaProtocol
      53. Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasisProtocol
      54. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinomaProtocol
      55. Sequential versus standard triple therapy for Helicobacter pylori eradicationProtocol
      56. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis and serum C-reactive protein, procalcitonin and lactate dehydrogenase for the diagnosis of pancreatic necrosisProtocolDiagnostic
      57. Somatostatin analogues for carcinoid syndromeProtocol
      58. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleedingProtocol
      59. Total pancreatectomy and islet autotransplantation for chronic pancreatitisProtocol
      60. Ultrasonography for confirmation of gastric tube placementProtocolDiagnostic
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH